🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
PRA
$PRAX
🔒 US EquitiesPraxis Precision Medicines I
AVG HISTORICAL GAP
-2.05%
MAX GAP RECORD
-38.91%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $PRAX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$PRAX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 09, 2026 Earnings Release 2026-11-09 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN) |
+9.79%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
+3.23%
|
| Feb 19, 2026 Earnings Release 2026-02-19 (BEFORE OPEN) |
-4.23%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN) |
-1.52%
|
| Aug 04, 2025 Earnings Release 2025-08-04 (BEFORE OPEN) |
-3.86%
|
| May 02, 2025 Earnings Release 2025-05-02 (BEFORE OPEN) |
+1.84%
|
| Feb 28, 2025 Earnings Release 2025-02-28 (BEFORE OPEN) |
-38.91%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
6.0%
Bullish Gaps (7)
Bearish Gaps (8)
Neutral / Flat (0)
📖 Intelligence Summary
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗